About Alladapt
Alladapt is a company based in Menlo Park (United States) founded in 2018 by Kari Nadeau.. Alladapt has raised $179 million across 3 funding rounds from investors including Novartis, Hercules Capital and Enavate Sciences. The company has 1 employees as of December 31, 2024. Alladapt operates in a competitive market with competitors including PureTech Health, Dren Bio, Adagene, Stallergenes Greer and IgGenix, among others.
- Headquarter Menlo Park, United States
- Employees 1 as on 31 Dec, 2024
- Founders Kari Nadeau
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alladapt Immunotherapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$179 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Novartis
& 6 more
-
Employee Count
1
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Alladapt
Alladapt has successfully raised a total of $179M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(20 Feb 2020)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Debt – Conventional - Alladapt | Valuation |
investors |
|
| Jun, 2022 | Amount | Series D - Alladapt | Valuation | Enavate Sciences | |
| Feb, 2020 | Amount | Series C - Alladapt | Valuation | Gurnet Point Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alladapt
Alladapt has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Hercules Capital and Enavate Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Investment partnerships are built and principal investments are made by B-FLEXION.
|
Founded Year | Domain | Location | |
|
Venture capital investments are focused on food allergy solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alladapt
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alladapt
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alladapt Comparisons
Competitors of Alladapt
Alladapt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PureTech Health, Dren Bio, Adagene, Stallergenes Greer and IgGenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies are developed for cancer, autoimmune, and serious diseases.
|
|
| domain | founded_year | HQ Location |
Immunotherapy antibodies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Allergen immunotherapies for respiratory allergies are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for food allergies are developed via antibody platforms.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics are developed for cancer treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alladapt
Frequently Asked Questions about Alladapt
When was Alladapt founded?
Alladapt was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Alladapt located?
Alladapt is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Alladapt a funded company?
Alladapt is a funded company, having raised a total of $179M across 3 funding rounds to date. The company's 1st funding round was a Series C of $60M, raised on Feb 20, 2020.
How many employees does Alladapt have?
As of Dec 31, 2024, the latest employee count at Alladapt is 1.
What does Alladapt do?
Alladapt was founded in 2018 and is based in Menlo Park, United States. Therapeutics are developed by the company for the treatment of food allergies, including a single investigational oral immunotherapy known as ADP101. This approach targets common allergens such as cows milk, eggs, tree nuts, peanuts, and shellfish. Prescription options are offered to manage a broad spectrum of food-related sensitivities in the biotechnology sector.
Who are the top competitors of Alladapt?
Alladapt's top competitors include Dren Bio, PureTech Health and Adagene.
Who are Alladapt's investors?
Alladapt has 7 investors. Key investors include Novartis, Hercules Capital, Enavate Sciences, B-FLEXION, and AllerFund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.